Premium
The value of ultrasound for monitoring ovarian responses to gonadotrophin stimulant therapy
Author(s) -
FINK RICHARD S.,
BOWES LESLEY P.,
MACKINTOSH COLIN E.,
SMITH W. I.,
GEORGIADES EMMANUEL,
GINSBURG JEAN
Publication year - 1982
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1982.tb05041.x
Subject(s) - medicine , ultrasound , follicular phase , pregnancy , ovulation , urinary system , gynecology , urology , obstetrics , endocrinology , biology , radiology , hormone , genetics
Summary. Ultrasonic measurement of ovarian follicles was used in conjunction with conventional measurement of urinary oestrogen output to monitor responses in infertile women receiving gonadotrophin stimulant therapy. In the 21 women who conceived during the first 15 months, in which this combined monitoring was used, ultrasound proved superior to oestrogen measurement alone for assessing follicular maturity and hence deciding when to administer the ovulating dose of chorionic gonadotrophin. The use of ultrasound imaging improves efficiency of treatment with gonatodrophin stimulant therapy, but is not predictive of multiple pregnancy or of hyperstimulation.